Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham
Beckham becomes a strategic investor in PreneticsBeckham and Prenetics are co-founding partners for IM8, a new health and wellness brand...
Day: July 11, 2024
Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds
CINCINNATI, Ohio, July 11, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (“Onconetix” or the “Company”) (Nasdaq: ONCO), today announced it has...
MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets
DALLAS, TEXAS, July 11, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on...
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
VANCOUVER, British Columbia, July 11, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the...
Fortrea Appoints Robert Parks as Chief Accounting Officer
DURHAM, N.C., July 11, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced...
3Daughters Secures $4.7 Million in Oversubscribed Seed Round
Funds will support development of game-changing IUD (intrauterine device) for contraception through an IND filing in early 2025MANSFIELD, Mass., July...
Palisade Bio Announces Successful Completion of First GMP Manufacturing of PALI-2108 Drug Substance and Engineering Batches of Drug Product
Company has now completed murine and non-murine pivotal nonclinical studies using GMP PALI-2108 drug substance Company has successfully formulated enteric-coated...
ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress
PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic...
Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational
Largest expansion in company’s 150+-year history opensMajor client project already underway; new clients actively being onboarded LAUPHEIM, Germany and MILFORD,...
Alignment Healthcare to Announce Second Quarter 2024 Financial Results and Host Conference Call Thursday, Aug. 1, 2024
ORANGE, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its second quarter 2024 financial...
Samsung Bioepis Releases Third Quarter 2024 US Biosimilar Market Report
Addresses frequently asked questions on biosimilar interchangeability and its exclusivity Includes an interview with Scripius’ pharmacy benefit manager on their...
STRATA Skin Sciences Pre-Announces Second Quarter 2024 Financial Results
HORSHAM, Penn., July 11, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical...
Lexeo Therapeutics Announces Investor Webcast to Report Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy on Monday, July 15, 2024
NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated...
Indianapolis Medical Oncologist Co-authors Research Presented at International Lymphoma Symposium
Hematology Oncology of Indiana’s M. Sarfraz Nawaz, MD, investigated improvement in approaches to febrile neutropenia in cancer patients Indianapolis Medical...
Acumen Pharmaceuticals to Present Patient Experience and Biomarker Insights from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024
NEWTON, Mass., July 11, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel...
Entero Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.9 Million Gross Proceeds
BOCA RATON, Fla., July 11, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (“Entero” or the “Company”) (NASDAQ: ENTO), a clinical-stage...
Daxor Corporation’s BVA-100™ Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide
Daxor's ezBVA Lab Service Emerges as Key Driver for Expansion and Market Penetration Oak Ridge, TN, July 11, 2024 (GLOBE...
Derek Chaves Appointed Chief Financial Officer of Corza Medical
WESTWOOD, Mass., July 11, 2024 (GLOBE NEWSWIRE) -- Corza Medical (“Corza” or the “Company”) is proud to announce the appointment...
Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona’s Patented AAV204 Capsid for Select Ophthalmology Indications
CLEVELAND and LONDON, July 11, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a cell and gene therapy company...
Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore
This marks the first export into Asia, the 18th international market for Aureus branded products and 21st market for all...